\-\ Texto\\:\\ \ \(0\)\
\-\ non\\-contributory\\.\\ \\ non\\-focal\\ neuro\\ exam\\.\ \(0\)\
\-\ neurosurgery\\ was\\ consulted\\ and\\ patient\\ underwent\\ surgery\\ with\\ ventriculo\\-peritoneal\\ shunt\\ placement\\ to\\ alleviate\\ pressure\\ and\\ to\\ prevent\\ any\\ further\\ complications\\.\\ \\ \ \(0\)\
\-\ endoscopic\\ ventriculostomy\\ is\\ an\\ alternative\\ to\\ the\\ shunt\\ surgery\\.\ \(0\)\
\-\ ct\\ imaging\\ without\\ contrast\\ showed\\ ventricular\\ enlargement\\ of\\ lateral\\ and\\ third\\ ventricles\\ with\\ a\\ normal\\ fourth\\ ventricle\\.\\ \\ subsequent\\ mri\\ confirmed\\ the\\ ct\\ findings\\ without\\ evidence\\ of\\ transependymal\\ flow\\ of\\ csf\\.\\ \\ high\\ resolution\\ mri\\ demonstrated\\ multiple\\ thin\\ septations\\ in\\ the\\ aqueduct\\ of\\ sylvius\\.\ \(0\)\
\-\ mr\\ imaging\\ with\\ cine\\ csf\\ flow\\ study\\ \\(not\\ depicted\\)\\ showed\\ no\\ significant\\ csf\\ flow\\ through\\ the\\ cerebral\\ aqueduct\\.\ \(0\)\
\-\ non\\ communicating\\ hydrocephalus\\ due\\ to\\ aqueductal\\ stenosis\ \(0\)\
\-\ communicating\\ vs\\.\\ non\\-communicating\\ hydrocephalus\ \(0\)\
\-\ 21\\ yr\\ old\\ pregnant\\ female\\ at\\ 11\\ wks\\ of\\ gestation\\ presents\\ with\\ two\\ weeks\\ history\\ of\\ severe\\ headache\\.\\ \\ she\\ reports\\ recent\\ mvc\\ one\\ week\\ prior\\ to\\ presentation\\ to\\ the\\ ed\\.\\ \\ subsequently\\,\\ she\\ noted\\ a\\ remote\\ history\\ of\\ salmonella\\ meningitis\\ as\\ a\\ child\\.\ \(0\)\
\-\ hydrocephalus\\ is\\ defined\\ as\\ an\\ active\\ distension\\ of\\ the\\ ventricular\\ system\\ due\\ to\\ inadequate\\ passage\\ of\\ csf\\ from\\ its\\ point\\ of\\ production\\ within\\ the\\ ventricular\\ system\\ to\\ its\\ point\\ of\\ absorption\\ into\\ the\\ systemic\\ circulation\\ \\(2\\)\\.\\ \\ the\\ incidence\\ of\\ hydrocephalus\\ is\\ equal\\ in\\ men\\ and\\ women\\.\\ \\ however\\,\\ there\\ are\\ a\\ few\\ exceptions\\ such\\ as\\ an\\ x\\-linked\\ hydrocephalus\\ and\\ normal\\ pressure\\ hydrocephalus\\ that\\ is\\ predominant\\ in\\ male\\ patients\\.\ \(0\)\
\-\ this\\ 21\\ yr\\ old\\ woman\\ presented\\ with\\ headache\\ and\\ was\\ diagnosed\\ with\\ aqueductal\\ stenosis\\.\\ \\ headache\\ is\\ the\\ most\\ common\\ clinical\\ manifestation\\ of\\ an\\ adult\\ with\\ aqueductal\\ stenosis\\.\\ \\ the\\ signs\\ and\\ symptoms\\ of\\ hydrocephalus\\ vary\\ with\\ age\\ and\\ disease\\ progression\\.\\ \\ a\\ symptomatic\\ adult\\ patient\\ could\\ have\\ additional\\ neurological\\ symptoms\\ such\\ as\\ nausea\\,\\ vomiting\\,\\ blurred\\ and\\ double\\ vision\\,\\ gait\\ impairment\\,\\ drowsiness\\ and\\ cognitive\\ deterioration\\.\\ \\ possible\\ physical\\ exam\\ findings\\ include\\ those\\ due\\ to\\ increased\\ intracranial\\ pressure\\ such\\ as\\ papilledema\\,\\ failure\\ of\\ upward\\ gaze\\ and\\ accommodation\\,\\ enlarged\\ head\\,\\ and\\ gait\\ instability\\(1\\)\\.\\ \\ \ \(0\)\
\-\ based\\ on\\ the\\ imaging\\ findings\\,\\ the\\ patient\\ suffered\\ from\\ chronic\\ hydrocephalus\\ because\\ there\\ was\\ no\\ significant\\ transependymal\\ flow\\ of\\ csf\\ or\\ sulcal\\ effacement\\ \\.\\ \\ chronic\\ hydrocephalus\\ are\\ typically\\ due\\ to\\ congenital\\ causes\\ or\\ longstanding\\ processes\\,\\ and\\ this\\ patient\\â\\€\\™s\\ aqueductal\\ septations\\ are\\ likely\\ associated\\ with\\ post\\-inflammatory\\ changes\\ and\\ sequelae\\ of\\ her\\ childhood\\ case\\ of\\ salmonella\\ meningitis\\.\\ \\ the\\ incidence\\ of\\ chronic\\ hydrocephalus\\ increases\\ with\\ increasing\\ age\\ and\\ clinical\\ symptoms\\ appear\\ when\\ hydrocephalus\\ decompensates\\ due\\ to\\ late\\ onset\\ of\\ aqueductal\\ stenosis\\ \\(3\\,4\\)\\.\\ \\ \ \(0\)\
\-\ in\\ order\\ to\\ relieve\\ the\\ pressure\\ and\\ improve\\ patient\\â\\€\\™s\\ clinical\\ manifestation\\,\\ this\\ patient\\ underwent\\ vp\\ shunt\\ placement\\.\\ \\ currently\\,\\ there\\ are\\ two\\ forms\\ of\\ surgical\\ treatment\\ for\\ aqueductal\\ stenosis\\:\\ shunt\\ placement\\ and\\ endoscopic\\ third\\ ventriculostomy\\.\\ \\ shunt\\ surgery\\ remains\\ the\\ standard\\ of\\ care\\ due\\ to\\ its\\ effectiveness\\,\\ but\\ etv\\ experience\\ is\\ growing\\ with\\ improving\\ patency\\ rates\\ and\\ avoids\\ shunt\\ malfunction\\ complications\\.\\ \\ after\\ obstruction\\ is\\ resolved\\,\\ a\\ patient\\â\\€\\™s\\ gait\\,\\ postural\\ function\\,\\ cognitive\\ functions\\ may\\ improve\\ \\(1\\)\\.\\ \\ this\\ patient\\ had\\ complete\\ resolution\\ of\\ headache\\.\ \(0\)\
\-\ references\\:\ \(0\)\
\-\ 1\\.\\	tisell\\,\\ m\\,\\ tullberg\\,\\ m\\,\\ hellstrom\\,\\ p\\,\\ blomsterwall\\,\\ e\\,\\ wikkelso\\,\\ c\\.\\ neurological\\ symptoms\\ and\\ signs\\ in\\ adult\\ aqueductal\\ stenosis\\.\\ acta\\ neurologica\\ scandinavica\\.\\ 2003\\;107\\(5\\)\\:311\\-317\\.\ \(0\)\
\-\ 2\\.\\	rekate\\,\\ hl\\.\\ a\\ contemporary\\ definition\\ and\\ classification\\ of\\ hydrocephalus\\.\\ seminars\\ in\\ pediatric\\ neurology\\.\\ 2009\\;\\ 16\\(1\\)\\:9\\-15\\.\ \(0\)\
\-\ 3\\.\\	partington\\ md\\.\\ congenital\\ hydrocephalus\\.\\ neurosurg\\ clin\\ n\\ am\\.\\ 2001\\;12\\(4\\)\\:737\\-42\\.\\ \ \(0\)\
\-\ 4\\.\\	edwards\\,\\ rj\\,\\ dombrowski\\,\\ sm\\,\\ luciano\\,\\ mg\\,\\ pople\\,\\ ik\\.\\ chronic\\ hydrocephalus\\ in\\ adults\\.\\ brain\\ pathol\\.\\ 2004\\;14\\(3\\)325\\-36\\.\ \(0\)\
\-\ 5\\.\\	tisell\\,\\ m\\.\\ how\\ should\\ primary\\ aqueductal\\ stenosis\\ in\\ adults\\ be\\ treated\\?\\ a\\ review\\.\\ acta\\ neurologica\\ scandinavica\\.\\ 2005\\;111\\(3\\)\\:145\\-153\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ aqueductal\\:\\ 0\\.08578667275633807\ \(0\)\
\-\ hydrocephalus\\:\\ 0\\.07653864307216329\ \(0\)\
\-\ shunt\\:\\ 0\\.0394738327615541\ \(0\)\
\-\ stenosis\\:\\ 0\\.03486935711282674\ \(0\)\
\-\ csf\\:\\ 0\\.026551297260461397\ \(0\)\
\-\ tisell\\:\\ 0\\.02623666197609077\ \(0\)\
\-\ scandinavica\\:\\ 0\\.02623666197609077\ \(0\)\
\-\ neurologica\\:\\ 0\\.02417372393870998\ \(0\)\
\-\ due\\:\\ 0\\.020359617437078925\ \(0\)\
\-\ transependymal\\:\\ 0\\.0200478478639484\ \(0\)\
\-\ acta\\:\\ 0\\.0200478478639484\ \(0\)\
\-\ pressure\\:\\ 0\\.019975791129894876\ \(0\)\
\-\ salmonella\\:\\ 0\\.019383730151703728\ \(0\)\
\-\ adult\\:\\ 0\\.0191201737982734\ \(0\)\
\-\ ventriculostomy\\:\\ 0\\.019100068902286094\ \(0\)\
\-\ aqueduct\\:\\ 0\\.017804479404494887\ \(0\)\
\-\ gait\\:\\ 0\\.017764448736674196\ \(0\)\
\-\ headache\\:\\ 0\\.01747015141408213\ \(0\)\
\-\ ventricular\\:\\ 0\\.01704600959911778\ \(0\)\
\-\ cognitive\\:\\ 0\\.016904833952492107\ \(0\)\
\-\ flow\\:\\ 0\\.016809844505110215\ \(0\)\
\-\ yr\\:\\ 0\\.016656674402078266\ \(0\)\
\-\ manifestation\\:\\ 0\\.016427623684411218\ \(0\)\
\-\ septations\\:\\ 0\\.015571427040209489\ \(0\)\
\-\ communicating\\:\\ 0\\.015489882474173433\ \(0\)\
\-\ placement\\:\\ 0\\.015483977202004595\ \(0\)\
\-\ \\;\\:\\ 0\\.015070098128367512\ \(0\)\
\-\ endoscopic\\:\\ 0\\.014974192827524513\ \(0\)\
\-\ its\\:\\ 0\\.014395229658284112\ \(0\)\
\-\ chronic\\:\\ 0\\.014327319243494046\ \(0\)\
\-\ \\,\\:\\ 0\\.014099482579025385\ \(0\)\
\-\ improve\\:\\ 0\\.013550114722991615\ \(0\)\
\-\ meningitis\\:\\ 0\\.013194916039561357\ \(0\)\
\-\ m\\:\\ 0\\.013121426121137633\ \(0\)\
\-\ decompensates\\:\\ 0\\.013118330988045384\ \(0\)\
\-\ etv\\:\\ 0\\.013118330988045384\ \(0\)\
\-\ avoids\\:\\ 0\\.013118330988045384\ \(0\)\
\-\ tullberg\\:\\ 0\\.013118330988045384\ \(0\)\
\-\ blomsterwall\\:\\ 0\\.013118330988045384\ \(0\)\
\-\ wikkelso\\:\\ 0\\.013118330988045384\ \(0\)\
\-\ \\:311\\-317\\:\\ 0\\.013118330988045384\ \(0\)\
\-\ rekate\\:\\ 0\\.013118330988045384\ \(0\)\
\-\ \\:9\\-15\\:\\ 0\\.013118330988045384\ \(0\)\
\-\ partington\\:\\ 0\\.013118330988045384\ \(0\)\
\-\ \\:737\\-42\\:\\ 0\\.013118330988045384\ \(0\)\
\-\ dombrowski\\:\\ 0\\.013118330988045384\ \(0\)\
\-\ luciano\\:\\ 0\\.013118330988045384\ \(0\)\
\-\ pople\\:\\ 0\\.013118330988045384\ \(0\)\
\-\ ik\\:\\ 0\\.013118330988045384\ \(0\)\
\-\ 325\\-36\\:\\ 0\\.013118330988045384\ \(0\)\
\-\ \\:145\\-153\\:\\ 0\\.013118330988045384\ \(0\)\
\-\ adults\\:\\ 0\\.01297967597533628\ \(0\)\
\-\ symptoms\\:\\ 0\\.012676532600584161\ \(0\)\
\-\ hellstrom\\:\\ 0\\.01208686196935499\ \(0\)\
\-\ hl\\:\\ 0\\.01208686196935499\ \(0\)\
\-\ edwards\\:\\ 0\\.01208686196935499\ \(0\)\
\-\ such\\:\\ 0\\.011925592811789518\ \(0\)\
\-\ clinical\\:\\ 0\\.011737990178866089\ \(0\)\
\-\ incidence\\:\\ 0\\.011659757809570199\ \(0\)\
\-\ 21\\:\\ 0\\.011508209921393838\ \(0\)\
\-\ sylvius\\:\\ 0\\.011483491272765458\ \(0\)\
\-\ drowsiness\\:\\ 0\\.011483491272765458\ \(0\)\
\-\ \\â\\€\\™\\:\\ 0\\.011401905087702927\ \(0\)\
\-\ point\\:\\ 0\\.011113434699351294\ \(0\)\
\-\ ventriculo\\-peritoneal\\:\\ 0\\.011055392950664595\ \(0\)\
\-\ exceptions\\:\\ 0\\.011055392950664595\ \(0\)\
\-\ malfunction\\:\\ 0\\.011055392950664595\ \(0\)\
\-\ seminars\\:\\ 0\\.011055392950664595\ \(0\)\
\-\ neurological\\:\\ 0\\.011004537534374236\ \(0\)\
\-\ resolution\\:\\ 0\\.010969106276914954\ \(0\)\
\-\ s\\:\\ 0\\.010940927085332978\ \(0\)\
\-\ \\(\\:\\ 0\\.010749430450057447\ \(0\)\
\-\ post\\-inflammatory\\:\\ 0\\.010723334094542259\ \(0\)\
\-\ \\)\\:\\ 0\\.010618120418352753\ \(0\)\
\-\ non\\-communicating\\:\\ 0\\.010452022254075063\ \(0\)\
\-\ contemporary\\:\\ 0\\.010452022254075063\ \(0\)\
\-\ alleviate\\:\\ 0\\.010222631361474976\ \(0\)\
\-\ 107\\:\\ 0\\.010222631361474976\ \(0\)\
\-\ third\\:\\ 0\\.010197758018303563\ \(0\)\
\-\ patient\\:\\ 0\\.010197522987099856\ \(0\)\
\-\ complications\\:\\ 0\\.01007789522325017\ \(0\)\
\-\ accommodation\\:\\ 0\\.0100239239319742\ \(0\)\
\-\ effectiveness\\:\\ 0\\.0100239239319742\ \(0\)\
\-\ functions\\:\\ 0\\.0100239239319742\ \(0\)\
\-\ system\\:\\ 0\\.01001333324524047\ \(0\)\
\-\ cine\\:\\ 0\\.009848651557485533\ \(0\)\
\-\ depicted\\:\\ 0\\.009848651557485533\ \(0\)\
\-\ x\\-linked\\:\\ 0\\.009848651557485533\ \(0\)\
\-\ 3\\,4\\:\\ 0\\.009848651557485533\ \(0\)\
\-\ sm\\:\\ 0\\.009848651557485533\ \(0\)\
\-\ pathol\\:\\ 0\\.009848651557485533\ \(0\)\
\-\ as\\:\\ 0\\.009617392156950354\ \(0\)\
\-\ absorption\\:\\ 0\\.009420553235384668\ \(0\)\
\-\ rj\\:\\ 0\\.009420553235384668\ \(0\)\
\-\ 111\\:\\ 0\\.009420553235384668\ \(0\)\
\-\ non\\-focal\\:\\ 0\\.00930144206325143\ \(0\)\
\-\ sulcal\\:\\ 0\\.00930144206325143\ \(0\)\
\-\ neurosurg\\:\\ 0\\.00930144206325143\ \(0\)\
\-\ congenital\\:\\ 0\\.009301068362031064\ \(0\)\
\-\ surgery\\:\\ 0\\.009263388680179799\ \(0\)\
\-\ wks\\:\\ 0\\.009088494379262332\ \(0\)\
\-\ 1\\:\\ 0\\.009077349856962976\ \(0\)\
\-\ signs\\:\\ 0\\.008950523613053733\ \(0\)\
\-\ imaging\\:\\ 0\\.008937829573462511\ \(0\)\
\-\ vp\\:\\ 0\\.008902239702247444\ \(0\)\
\-\ patency\\:\\ 0\\.008817182538795139\ \(0\)\
\-\ mvc\\:\\ 0\\.0087367253642858\ \(0\)\
\-\ deterioration\\:\\ 0\\.0087367253642858\ \(0\)\
\-\ upward\\:\\ 0\\.0087367253642858\ \(0\)\
\-\ postural\\:\\ 0\\.0087367253642858\ \(0\)\
\-\ underwent\\:\\ 0\\.008726773915113747\ \(0\)\
\-\ alternative\\:\\ 0\\.008660396057161469\ \(0\)\
\-\ gaze\\:\\ 0\\.008660396057161469\ \(0\)\
\-\ blurred\\:\\ 0\\.008518565432452652\ \(0\)\
\-\ improving\\:\\ 0\\.008518565432452652\ \(0\)\
\-\ inadequate\\:\\ 0\\.008452416976246054\ \(0\)\
\-\ longstanding\\:\\ 0\\.008452416976246054\ \(0\)\
\-\ showed\\:\\ 0\\.008338700202153859\ \(0\)\
\-\ to\\:\\ 0\\.008261734240712531\ \(0\)\
\-\ predominant\\:\\ 0\\.008213811842205609\ \(0\)\
\-\ findings\\:\\ 0\\.008119807749062319\ \(0\)\
\-\ vary\\:\\ 0\\.00810747409818456\ \(0\)\
\-\ 2009\\:\\ 0\\.00810747409818456\ \(0\)\
\-\ definition\\:\\ 0\\.008057025360571938\ \(0\)\
\-\ passage\\:\\ 0\\.00791519473586312\ \(0\)\
\-\ papilledema\\:\\ 0\\.00791519473586312\ \(0\)\
\-\ suffered\\:\\ 0\\.00791519473586312\ \(0\)\
\-\ relieve\\:\\ 0\\.007870770683557049\ \(0\)\
\-\ consulted\\:\\ 0\\.0077449412370867166\ \(0\)\
\-\ circulation\\:\\ 0\\.0077449412370867166\ \(0\)\
\-\ neurology\\:\\ 0\\.0077449412370867166\ \(0\)\
\-\ age\\:\\ 0\\.007740804540310436\ \(0\)\
\-\ production\\:\\ 0\\.007705256345595405\ \(0\)\
\-\ impairment\\:\\ 0\\.0075921820792592114\ \(0\)\
\-\ sequelae\\:\\ 0\\.007556322627504657\ \(0\)\
\-\ e\\:\\ 0\\.007556322627504657\ \(0\)\
\-\ how\\:\\ 0\\.007521307006358535\ \(0\)\
\-\ pregnant\\:\\ 0\\.007487096413762257\ \(0\)\
\-\ clin\\:\\ 0\\.007487096413762257\ \(0\)\
\-\ increases\\:\\ 0\\.007453654663982409\ \(0\)\
\-\ m\\.\\:\\ 0\\.007453654663982409\ \(0\)\
\-\ distension\\:\\ 0\\.0073889446759768445\ \(0\)\
\-\ forms\\:\\ 0\\.0073889446759768445\ \(0\)\
\-\ rates\\:\\ 0\\.0073889446759768445\ \(0\)\
\-\ n\\:\\ 0\\.0073889446759768445\ \(0\)\
\-\ remote\\:\\ 0\\.00735761519800388\ \(0\)\
\-\ c\\.\\:\\ 0\\.00735761519800388\ \(0\)\
\-\ two\\:\\ 0\\.007283723921476207\ \(0\)\
\-\ classification\\:\\ 0\\.007267399986967518\ \(0\)\
\-\ men\\:\\ 0\\.007182342823515214\ \(0\)\
\-\ neurosurgery\\:\\ 0\\.007155037557639921\ \(0\)\
\-\ childhood\\:\\ 0\\.007155037557639921\ \(0\)\
\-\ she\\:\\ 0\\.0071392444686136074\ \(0\)\
\-\ an\\:\\ 0\\.007033719430266249\ \(0\)\
\-\ growing\\:\\ 0\\.007025556341881544\ \(0\)\
\-\ effacement\\:\\ 0\\.006976761962680664\ \(0\)\
\-\ experience\\:\\ 0\\.006976761962680664\ \(0\)\
\-\ mg\\:\\ 0\\.006976761962680664\ \(0\)\
\-\ gestation\\:\\ 0\\.006952951930915127\ \(0\)\
\-\ are\\:\\ 0\\.006933773050771438\ \(0\)\
\-\ processes\\:\\ 0\\.006883725717172726\ \(0\)\
\-\ 2005\\:\\ 0\\.006861347923475494\ \(0\)\
\-\ 2004\\:\\ 0\\.006839301664866654\ \(0\)\
\-\ significant\\:\\ 0\\.006838830806708998\ \(0\)\
\-\ 2001\\:\\ 0\\.00675424450141435\ \(0\)\
\-\ equal\\:\\ 0\\.00665433482457264\ \(0\)\
\-\ late\\:\\ 0\\.006616176445683745\ \(0\)\
\-\ remains\\:\\ 0\\.006616176445683745\ \(0\)\
\-\ neuro\\:\\ 0\\.006560713060568817\ \(0\)\
\-\ instability\\:\\ 0\\.006542675321681399\ \(0\)\
\-\ am\\:\\ 0\\.006542675321681399\ \(0\)\
\-\ p\\:\\ 0\\.006524853608814262\ \(0\)\
\-\ standard\\:\\ 0\\.006507242808744318\ \(0\)\
\-\ 2003\\:\\ 0\\.006389478938865265\ \(0\)\
\-\ order\\:\\ 0\\.0063733912660911335\ \(0\)\
\-\ progression\\:\\ 0\\.0063261461793134854\ \(0\)\
\-\ prevent\\:\\ 0\\.006310725365272493\ \(0\)\
\-\ md\\:\\ 0\\.006280355020583197\ \(0\)\
\-\ women\\:\\ 0\\.0061786894789500465\ \(0\)\
\-\ resolved\\:\\ 0\\.006164716651048499\ \(0\)\
\-\ fourth\\:\\ 0\\.006150873804824819\ \(0\)\
\-\ double\\:\\ 0\\.006150873804824819\ \(0\)\
\-\ pediatric\\:\\ 0\\.006123568538949526\ \(0\)\
\-\ systemic\\:\\ 0\\.006083527686390115\ \(0\)\
\-\ without\\:\\ 0\\.005988134423685\ \(0\)\
\-\ ventricles\\:\\ 0\\.005981737914240709\ \(0\)\
\-\ 3\\:\\ 0\\.005955284305674225\ \(0\)\
\-\ vision\\:\\ 0\\.00587497615105791\ \(0\)\
\-\ is\\:\\ 0\\.005857195608174225\ \(0\)\
\-\ mri\\:\\ 0\\.005843082901531607\ \(0\)\
\-\ 11\\:\\ 0\\.005818814948702483\ \(0\)\
\-\ those\\:\\ 0\\.005786108242275734\ \(0\)\
\-\ subsequently\\:\\ 0\\.0057646964305910625\ \(0\)\
\-\ 16\\:\\ 0\\.005754104960696919\ \(0\)\
\-\ few\\:\\ 0\\.005722775482723955\ \(0\)\
\-\ this\\:\\ 0\\.005721054841155554\ \(0\)\
\-\ there\\:\\ 0\\.005677301591361556\ \(0\)\
\-\ 14\\:\\ 0\\.005603664310590716\ \(0\)\
\-\ exam\\:\\ 0\\.00558700577365934\ \(0\)\
\-\ child\\:\\ 0\\.0055659890010902845\ \(0\)\
\-\ review\\:\\ 0\\.005511206302991004\ \(0\)\
\-\ 5\\.\\:\\ 0\\.005484553138457477\ \(0\)\
\-\ function\\:\\ 0\\.005390716626601619\ \(0\)\
\-\ ed\\:\\ 0\\.005374273417990629\ \(0\)\
\-\ intracranial\\:\\ 0\\.005374273417990629\ \(0\)\
\-\ defined\\:\\ 0\\.00535800992017487\ \(0\)\
\-\ and\\:\\ 0\\.005357410884887454\ \(0\)\
\-\ references\\:\\ 0\\.005286946778365495\ \(0\)\
\-\ non\\:\\ 0\\.005256420677423377\ \(0\)\
\-\ thin\\:\\ 0\\.005226508208195569\ \(0\)\
\-\ increasing\\:\\ 0\\.005211774471614153\ \(0\)\
\-\ appear\\:\\ 0\\.005204461949586728\ \(0\)\
\-\ 12\\:\\ 0\\.005204461949586728\ \(0\)\
\-\ reports\\:\\ 0\\.005126310112855409\ \(0\)\
\-\ nausea\\:\\ 0\\.005119404786134424\ \(0\)\
\-\ additional\\:\\ 0\\.0050988790091517815\ \(0\)\
\-\ symptomatic\\:\\ 0\\.00505205866769972\ \(0\)\
\-\ enlargement\\:\\ 0\\.00504548870012663\ \(0\)\
\-\ currently\\:\\ 0\\.005038947611625085\ \(0\)\
\-\ in\\:\\ 0\\.005016633692145891\ \(0\)\
\-\ vs\\:\\ 0\\.005006666622620235\ \(0\)\
\-\ 4\\.\\:\\ 0\\.005006666622620235\ \(0\)\
\-\ failure\\:\\ 0\\.004981336730403819\ \(0\)\
\-\ \\?\\:\\ 0\\.004962618304500754\ \(0\)\
\-\ subsequent\\:\\ 0\\.004950268895550314\ \(0\)\
\-\ causes\\:\\ 0\\.004950268895550314\ \(0\)\
\-\ active\\:\\ 0\\.0048549982723882145\ \(0\)\
\-\ vomiting\\:\\ 0\\.0048549982723882145\ \(0\)\
\-\ based\\:\\ 0\\.00484924161051631\ \(0\)\
\-\ confirmed\\:\\ 0\\.004781844647450591\ \(0\)\
\-\ ventricle\\:\\ 0\\.004765461782110756\ \(0\)\
\-\ a\\:\\ 0\\.004721426212126205\ \(0\)\
\-\ non\\-contributory\\:\\ 0\\.004696482452688805\ \(0\)\
\-\ could\\:\\ 0\\.00469130646403356\ \(0\)\
\-\ diagnosed\\:\\ 0\\.004675885649992568\ \(0\)\
\-\ care\\:\\ 0\\.004586573135518976\ \(0\)\
\-\ typically\\:\\ 0\\.004488728823669601\ \(0\)\
\-\ obstruction\\:\\ 0\\.004484226262781898\ \(0\)\
\-\ complete\\:\\ 0\\.0044752618065268665\ \(0\)\
\-\ because\\:\\ 0\\.00444868797111019\ \(0\)\
\-\ was\\:\\ 0\\.0044119532241682444\ \(0\)\
\-\ cerebral\\:\\ 0\\.00440542634191082\ \(0\)\
\-\ presentation\\:\\ 0\\.004380060467992682\ \(0\)\
\-\ 3\\.\\:\\ 0\\.004351003291876082\ \(0\)\
\-\ enlarged\\:\\ 0\\.0043387218309285805\ \(0\)\
\-\ week\\:\\ 0\\.004318475324893196\ \(0\)\
\-\ possible\\:\\ 0\\.004282711635244155\ \(0\)\
\-\ recent\\:\\ 0\\.004274879536963983\ \(0\)\
\-\ study\\:\\ 0\\.004183975233422558\ \(0\)\
\-\ of\\:\\ 0\\.004160850028499586\ \(0\)\
\-\ should\\:\\ 0\\.004053881758763095\ \(0\)\
\-\ further\\:\\ 0\\.004043815687202765\ \(0\)\
\-\ 2\\.\\:\\ 0\\.004043815687202765\ \(0\)\
\-\ mr\\:\\ 0\\.004040475404682193\ \(0\)\
\-\ onset\\:\\ 0\\.004014019681436235\ \(0\)\
\-\ any\\:\\ 0\\.0040042187992147225\ \(0\)\
\-\ normal\\:\\ 0\\.003986941829163991\ \(0\)\
\-\ 1\\.\\:\\ 0\\.0039720076879428586\ \(0\)\
\-\ severe\\:\\ 0\\.003912663392955363\ \(0\)\
\-\ brain\\:\\ 0\\.0038264159572957766\ \(0\)\
\-\ her\\:\\ 0\\.0038235292536978206\ \(0\)\
\-\ treated\\:\\ 0\\.003806325648934314\ \(0\)\
\-\ from\\:\\ 0\\.0037691539081970604\ \(0\)\
\-\ primary\\:\\ 0\\.0037669408674043097\ \(0\)\
\-\ demonstrated\\:\\ 0\\.0037312797357990585\ \(0\)\
\-\ 5\\:\\ 0\\.0037204768191133383\ \(0\)\
\-\ changes\\:\\ 0\\.003644416631302173\ \(0\)\
\-\ when\\:\\ 0\\.0036418619607381034\ \(0\)\
\-\ through\\:\\ 0\\.0036115431821739114\ \(0\)\
\-\ weeks\\:\\ 0\\.0036090442811028993\ \(0\)\
\-\ head\\:\\ 0\\.0036065495693063925\ \(0\)\
\-\ likely\\:\\ 0\\.003586741020737584\ \(0\)\
\-\ include\\:\\ 0\\.00356719269052126\ \(0\)\
\-\ ct\\:\\ 0\\.0035574513493810797\ \(0\)\
\-\ 4\\:\\ 0\\.003543112954135484\ \(0\)\
\-\ however\\:\\ 0\\.003540726273209926\ \(0\)\
\-\ history\\:\\ 0\\.003512543266985367\ \(0\)\
\-\ high\\:\\ 0\\.003479979257554785\ \(0\)\
\-\ presented\\:\\ 0\\.0034663060044976325\ \(0\)\
\-\ one\\:\\ 0\\.0034460288442122677\ \(0\)\
\-\ \\:\\:\\ 0\\.00336391314282936\ \(0\)\
\-\ evidence\\:\\ 0\\.003333991939534044\ \(0\)\
\-\ common\\:\\ 0\\.003327778589220829\ \(0\)\
\-\ the\\:\\ 0\\.003291649635800614\ \(0\)\
\-\ patients\\:\\ 0\\.003291033630008967\ \(0\)\
\-\ prior\\:\\ 0\\.0032650487681582787\ \(0\)\
\-\ physical\\:\\ 0\\.0031197995083054137\ \(0\)\
\-\ increased\\:\\ 0\\.0031108404491066305\ \(0\)\
\-\ into\\:\\ 0\\.0030257832856543255\ \(0\)\
\-\ noted\\:\\ 0\\.0030140196256735023\ \(0\)\
\-\ associated\\:\\ 0\\.0030006883361721752\ \(0\)\
\-\ or\\:\\ 0\\.0029807224671538914\ \(0\)\
\-\ woman\\:\\ 0\\.002937355576620396\ \(0\)\
\-\ most\\:\\ 0\\.002935766579952494\ \(0\)\
\-\ contrast\\:\\ 0\\.0028463923910831924\ \(0\)\
\-\ may\\:\\ 0\\.0027891791203841125\ \(0\)\
\-\ case\\:\\ 0\\.002782000644147724\ \(0\)\
\-\ have\\:\\ 0\\.002753628092805196\ \(0\)\
\-\ lateral\\:\\ 0\\.0027480179250365332\ \(0\)\
\-\ had\\:\\ 0\\.0027438241357748633\ \(0\)\
\-\ 2\\:\\ 0\\.002738250738854979\ \(0\)\
\-\ but\\:\\ 0\\.0027120584836808595\ \(0\)\
\-\ multiple\\:\\ 0\\.0026782827432727213\ \(0\)\
\-\ surgical\\:\\ 0\\.0026729490628741867\ \(0\)\
\-\ after\\:\\ 0\\.0026309541705494084\ \(0\)\
\-\ female\\:\\ 0\\.002614226594416419\ \(0\)\
\-\ old\\:\\ 0\\.0026039720144709956\ \(0\)\
\-\ presents\\:\\ 0\\.002597684963553461\ \(0\)\
\-\ treatment\\:\\ 0\\.0025738347613108435\ \(0\)\
\-\ no\\:\\ 0\\.0025608456866184582\ \(0\)\
\-\ \\.\\:\\ 0\\.0024300277685683465\ \(0\)\
\-\ within\\:\\ 0\\.002425790786288812\ \(0\)\
\-\ male\\:\\ 0\\.0022994130028087395\ \(0\)\
\-\ that\\:\\ 0\\.002196399893688725\ \(0\)\
\-\ disease\\:\\ 0\\.0020784784839519405\ \(0\)\
\-\ be\\:\\ 0\\.001960947504976085\ \(0\)\
\-\ with\\:\\ 0\\.001915246930042838\ \(0\)\
\-\ not\\:\\ 0\\.001837527785330261\ \(0\)\
\-\ at\\:\\ 0\\.0017228618345708822\ \(0\)\
\-\ for\\:\\ 0\\.0010849823640516594\ \(0\)\
\-\ on\\:\\ 0\\.0010772187684009345\ \(0\)\
